The author (Guy Villax) presents arguments for an FDA Dean's List as a means to drive the right behaviors in the industry.

FDA is moving in the right direction when it looks to rank quality across pharmaceutical manufacturing sites. However quality is a matter of culture rather than metrics or compliance.

• Read the extended version with links to references, examples and case studies here
• Read the article in Pharmaceutical Technology  here